Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susu Zhou

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Critical Reviews in Oncology/Hematology|May 14, 2024
Letter to the Editor regarding the article "A net-work meta-analysis of the cardiac safety for next-generation hormonal agents in treating castration-resistant prostate cancer: How to choose drugs appropriately?"Susu Zhou, Parissa Alerasool, Che-Kai Tsao
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
CLO26-075: Are PARP Inhibitors Effective Beyond Homologous Recombination Repair-Deficiency in Castration-Resistant Prostate Cancer? A Meta-AnalysisSusu Zhou, Devashish Desai, Sam Benjamin, et al.
Clinical Genitourinary Cancer|June 22, 2025
Do Older Patients With Metastatic Hormone-Sensitive Prostate Cancer Benefit From Triplet or Doublet Therapy? A Network Meta-AnalysisSusu Zhou, Parissa Alerasool, Noriko Kishi, et al.
Targeted Oncology|June 1, 2024
Adverse Event Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-small Cell Lung Cancer: An Updated Meta-analysisSusu Zhou, Noriko Kishi, Parissa Alerasool, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 30, 2026
CLO26-075: Are PARP Inhibitors Effective Beyond Homologous Recombination Repair-Deficiency in Castration-Resistant Prostate Cancer? A Meta-AnalysisSusu Zhou, Devashish Desai, Sam Benjamin, et al.
Therapeutic Advances in Medical Oncology|June 7, 2024
Endocrine adverse events in patients with cancer receiving perioperative immune checkpoint blockade: a meta-analysis of randomized controlled trialsSusu Zhou, Nobuyuki Horita, Theresa Shao, et al.
Targeted Oncology|December 3, 2025
Can PARP Inhibitors Benefit Patients with Homologous Recombination Repair-Proficient Castration-Resistant Prostate Cancer? A Meta-analysisSusu Zhou, Devashish Desai, Noriko Kishi, et al.
BMC Medical Imaging|June 9, 2026
A novel description of dynamic organ-specific trajectories in pelvic organ prolapse based on magnetic resonance imaging tracesXiaoman Hou, Susu Zhou, Fuqing Feng, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|May 29, 2010
[Study on preventative and curative effects of astragaloside (AST) on mice memory impairment and expression of amyloid precursor protein and beta secretase mRNA induced by dexamethasone]Wen Zhang, Weizu Li, Weiping Li, et al.
The Analyst|September 13, 2021
A facile aptamer immobilization strategy to fabricate a robust affinity monolith for highly specific in-tube solid-phase microextractionTingting Zhao, Shiqian Tong, Susu Zhou, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Critical Reviews in Oncology/Hematology|May 14, 2024
Letter to the Editor regarding the article "A net-work meta-analysis of the cardiac safety for next-generation hormonal agents in treating castration-resistant prostate cancer: How to choose drugs appropriately?"Susu Zhou, Parissa Alerasool, Che-Kai Tsao
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
CLO26-075: Are PARP Inhibitors Effective Beyond Homologous Recombination Repair-Deficiency in Castration-Resistant Prostate Cancer? A Meta-AnalysisSusu Zhou, Devashish Desai, Sam Benjamin, et al.
Clinical Genitourinary Cancer|June 22, 2025
Do Older Patients With Metastatic Hormone-Sensitive Prostate Cancer Benefit From Triplet or Doublet Therapy? A Network Meta-AnalysisSusu Zhou, Parissa Alerasool, Noriko Kishi, et al.
Targeted Oncology|June 1, 2024
Adverse Event Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-small Cell Lung Cancer: An Updated Meta-analysisSusu Zhou, Noriko Kishi, Parissa Alerasool, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 30, 2026
CLO26-075: Are PARP Inhibitors Effective Beyond Homologous Recombination Repair-Deficiency in Castration-Resistant Prostate Cancer? A Meta-AnalysisSusu Zhou, Devashish Desai, Sam Benjamin, et al.
Therapeutic Advances in Medical Oncology|June 7, 2024
Endocrine adverse events in patients with cancer receiving perioperative immune checkpoint blockade: a meta-analysis of randomized controlled trialsSusu Zhou, Nobuyuki Horita, Theresa Shao, et al.
Targeted Oncology|December 3, 2025
Can PARP Inhibitors Benefit Patients with Homologous Recombination Repair-Proficient Castration-Resistant Prostate Cancer? A Meta-analysisSusu Zhou, Devashish Desai, Noriko Kishi, et al.
BMC Medical Imaging|June 9, 2026
A novel description of dynamic organ-specific trajectories in pelvic organ prolapse based on magnetic resonance imaging tracesXiaoman Hou, Susu Zhou, Fuqing Feng, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|May 29, 2010
[Study on preventative and curative effects of astragaloside (AST) on mice memory impairment and expression of amyloid precursor protein and beta secretase mRNA induced by dexamethasone]Wen Zhang, Weizu Li, Weiping Li, et al.
The Analyst|September 13, 2021
A facile aptamer immobilization strategy to fabricate a robust affinity monolith for highly specific in-tube solid-phase microextractionTingting Zhao, Shiqian Tong, Susu Zhou, et al.
Pageof 2